| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |
| 03/18/2004 | US20040055040 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 03/18/2004 | US20040055039 Expression vector coding regulatory sequence for transcription of heterologous nucleotide sequences in fruit of plants; tissue engineering |
| 03/18/2004 | US20040055036 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054134 Hcv ns2/3 fragments and uses thereof |
| 03/18/2004 | US20040053893 Comprises lysophospholipids attached to chromophore; enzyme inhibitors; drug screening; kits |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053835 Reagents which regulate and bind to human NMDA receptor gene products can play role in preventing, ameliorating, or correcting dysfunctions or diseases including asthma, genito-urinary system disorders |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053413 Escherichia mutant lacking endogenous plasmids for use as gene propagation and genetic engineering tools |
| 03/18/2004 | US20040053412 Cells resistant to toxic genes and uses thereof |
| 03/18/2004 | US20040053400 Clavaria pulchra fungus and method for isolating clavarioid fungi |
| 03/18/2004 | US20040053397 Comprises sodium glucose transport proteins for treating diabetes and hyperlipidemia; drug screening |
| 03/18/2004 | US20040053393 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 03/18/2004 | US20040053387 Comprises nucleotide sequences coding pholem immobilized transferase fused to insecticidal proteins for generating disease resistant plants |
| 03/18/2004 | US20040053386 Terpene synthase having a region with 20% or greater sequence identity to specific residues of perferential amino acid sequence, and such synthase containing nine alpha-carbon having interatomic distance +-2.3 Angstroms between alpha C |
| 03/18/2004 | US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 03/18/2004 | US20040053374 Preparing, fermenting and recovering vitamin b from bacillus culture; biosynthesis of coenzyme A |
| 03/18/2004 | US20040053368 Collagen-binding hybrid polypeptide |
| 03/18/2004 | US20040053360 Preparing proteolytic polypeptide comprising amino acid attachment at carboxy-terminal for reducing odors generated when washing textiles solied with milk fat |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053344 Using human leukocyte antigen protein-f to classify and identify cell proliferative disorders |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053314 ADAM20 (SVPH1-26) DNA and polypeptides |
| 03/18/2004 | US20040053299 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 03/18/2004 | US20040053296 Method for localizing polypeptide on cell surface |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053279 Thermostable polymerases from thermococcus pacificus |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053276 Comprises protein factors for diagnosis, prevention and treatment of cancers, infections, immunological, gastrointestinal, organ and endocrine disorders; animal models for disease |
| 03/18/2004 | US20040053273 Comprises expression vector coding nitrilase transcription regulatory protein and promoter for transformation and expression of heterologous protein in streptomyces |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053259 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 03/18/2004 | US20040053238 Comprises xylanolytic polypeptides for use in food processing/thickening, detergents, textile treatment and paper making |
| 03/18/2004 | US20040053226 Comprises nucleotide sequences coding proteolytic enzyme for use in diagnosis, prevention and treatment of liver disorders |
| 03/18/2004 | US20040053207 Preservation of cells |
| 03/18/2004 | US20040052903 Strains of lactobacillus paracasei |
| 03/18/2004 | US20040052816 Recombinant protective protein from streptococcus pneumoniale |
| 03/18/2004 | US20040052813 Polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits and the diagnostic kits |
| 03/18/2004 | US20040052802 Attenuated mutant; prevent inferctions, diarrhea; human and veterinary medicine |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052779 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 03/18/2004 | US20040052767 Method for cell adhesion and wound healing |
| 03/18/2004 | US20040052764 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/18/2004 | DE10242763A1 New polynucleotide encoding mutant human glucose transporter, useful for identifying antidiabetic agents that can be used to treat diabetes types I or II |
| 03/18/2004 | DE10005114B4 Verfahren zur Biomasse-Rückhaltung bei Biogasreaktoren sowie Vorrichtung zur Durchführung des Verfahrens A process for the biomass retention in biogas reactors, and device for carrying out the method |
| 03/18/2004 | CA2498243A1 Method for isolating and culturing unculturable microorganisms |
| 03/18/2004 | CA2497989A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2497499A1 Use of malate dehydrogenase for nadh regeneration |
| 03/18/2004 | CA2497411A1 Methods for identifying antimicrobial compounds |
| 03/18/2004 | CA2497264A1 Heavy metal adsorbent composition comprising bacillus or staphylococcus bacteria |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/17/2004 | EP1398385A1 Assay using marked microbial host cell strains |
| 03/17/2004 | EP1398381A1 A microbial oxidoreductase |
| 03/17/2004 | EP1398379A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
| 03/17/2004 | EP1398372A1 Lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 03/17/2004 | EP1398369A1 Bifidobacteria and preparations containing them |
| 03/17/2004 | EP1398367A1 Cleaning compositions containing multiply-substituted protease variants |
| 03/17/2004 | EP1398326A2 Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 03/17/2004 | EP1398072A1 A vessel for mixing a cell lysate |
| 03/17/2004 | EP1398036A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/17/2004 | EP1397515A2 Nucleotide sequences involved in plant disease resistance |
| 03/17/2004 | EP1397513A2 Novel technology for genetic mapping |
| 03/17/2004 | EP1397504A2 Culture medium for detecting and/or discriminating enterococcus and method therefor |
| 03/17/2004 | EP1397494A2 Fungal gene cluster associated with pathogenesis |
| 03/17/2004 | EP1397492A2 Modified and stabilized gdf propeptides and uses thereof |
| 03/17/2004 | EP1397482A1 Method and device for anaerobically fermenting organic material |
| 03/17/2004 | EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 03/17/2004 | EP1397151A2 Wnv core protein/capsid interacting protein and uses of the same |
| 03/17/2004 | EP0975775B1 Regulatory system for inducible expression of genes with lambdoid promoters |
| 03/17/2004 | EP0952981B1 Method for producing a correctly folded, biological active recombinant protein |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0871715B1 A method for direct cloning of nuclease genes in e.coli |
| 03/17/2004 | CN1483080A Fermentative production of D-p-hydroxyphenylglycine and D-phenylglycine |
| 03/17/2004 | CN1482916A Vaccine composite containing invert growth factor a |
| 03/17/2004 | CN1482255A Method for producing protein feed by fermenting the waste water from saponin production |
| 03/17/2004 | CN1482247A Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses |
| 03/17/2004 | CN1482246A Preparation of alpha-1,4-glucan lyase and nucleic acid encoding same |
| 03/17/2004 | CN1482240A Thermostable or thermoactive dna polymerase with attenuated 3'-5' exonuclease activity |
| 03/17/2004 | CN1482237A 固体水 Solid Water |
| 03/17/2004 | CN1482236A Chrome-enriched yeast production method from edible yeast |
| 03/17/2004 | CN1482235A Process for preparing edible medicinal fungus and feed from dregs |
| 03/17/2004 | CN1482229A Sterilization method for beer yeast |
| 03/17/2004 | CN1481825A Oral compositions for white blood cell activation and proliferation |
| 03/17/2004 | CN1481824A Oral compositions for hiv-infected subjects |
| 03/17/2004 | CN1481823A Dietary supplements beneficial for the liver |
| 03/17/2004 | CN1481723A Dietary supplements for regulating male hormone |
| 03/17/2004 | CN1481722A Dietary supplements for improving memory |
| 03/17/2004 | CN1142281C Production method of recombined erythropoietin preparation |
| 03/17/2004 | CN1142280C Improved prokaryotic expression of protein |